Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Feltquate currently holds 350,000 shares of iTeos Therapeutics, Inc. (ITOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Feltquate has been a net neutral trader of ITOS stock. They have purchased $0 and sold $0 worth of shares.
David Feltquate's most recent insider trade was on Aug 29, 2025, when they sold 47,000 shares at $0.00 per share.
David Feltquate serves as Executive at iTeos Therapeutics, Inc. (ITOS). They have executed 2 insider transactions totaling $0 over their tenure at the company.
David Feltquate holds the position of Executive at iTeos Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
David Feltquate has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by David Feltquate was on Aug 29, 2025, when they sold $0 worth of ITOS shares. This transaction involved 47,000 shares at N/A per share.
David Feltquate currently owns 350,000 shares of iTeos Therapeutics, Inc. (ITOS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Feltquate's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Feltquate has 2 Form 4 filings on record as an insider at iTeos Therapeutics, Inc..
Set alerts for David Feltquate and 40,000+ other insiders.